20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

Rexahn Pharmaceuticals, Inc. REXN stock increased by 44.72% to $4.11 during Thursday's pre-market session.

Eloxx Pharmaceuticals, Inc. ELOX stock rose 27.87% to $3.90. The most recent rating by Citigroup, on Jun 11, is at Neutral, with a price target of $4.

Tonix Pharmaceuticals, Inc. TNXP shares rose 27.59% to $0.80.

Evolus, Inc. EOLS shares increased by 24.06% to $6.24. The most recent rating by Mizuho, on May 12, is at Buy, with a price target of $8.

Biocept, Inc. BIOC stock rose 11.56% to $0.72.

Forward Pharma, Inc. FWP stock increased by 10.51% to $8.20.

Sunesis Pharmaceuticals, Inc. SNSS stock increased by 10.05% to $0.65. The most recent rating by H.C. Wainwright, on May 8, is at Neutral, with a price target of $0.

Royalty Pharma, Inc. RPRX shares rose 9.65% to $53.30.

Regulus Therapeutics, Inc. RGLS shares moved upwards by 8.76% to $0.96. The most recent rating by HC Wainwright & Co., on May 4, is at Buy, with a price target of $2.

Celsion, Inc. CLSN shares increased by 8% to $4.59.

 

Losers

Brickell Biotech, Inc. BBI stock decreased by 17.05% to $1.07 during Thursday's pre-market session.

Zealand Pharma, Inc. ZEAL stock declined 11.21% to $36.21. The most recent rating by Morgan Stanley, on Apr 15, is at Overweight, with a price target of $37.

Catalyst Biosciences, Inc. CBIO shares declined 9.90% to $6.55.

Millendo Therapeutics, Inc. MLND shares declined 8.84% to $2.99. The most recent rating by Citigroup, on May 29, is at Buy, with a price target of $6.

Miragen Therapeutics, Inc. MGEN stock decreased by 7.94% to $1.16.

IVERIC bio, Inc. ISEE shares decreased by 7.66% to $4.10.

Precipio, Inc. PRPO shares fell 6.19% to $1.06.

Brainsway, Inc. BWAY stock fell 4.95% to $6.72. The most recent rating by Raymond James, on Mar 24, is at Outperform, with a price target of $9.

Ra Medical Systems, Inc. RMED shares fell 4.85% to $0.59. The most recent rating by Piper Sandler, on May 14, is at Neutral, with a price target of $1.

Titan Pharmaceuticals, Inc. TTNP stock fell 4.62% to $0.31.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...